Mounjaro Maker Eli Lilly Banks On Bigger 2026 Thanks To Weight Loss Drugs

Eli Lilly and Co. (NYSE:LLY) stock is trading higher after the company released better-than-expected Q4 earnings and issued fiscal 2026 guidance.Earnings OverviewEli Lilly reported fourth-quarter adjusted earnings of $7.54 per share, beating the consensus of $6.67.The company's sales reached $19.3 billion, beating the consensus of $17.96 billion.Sales jumped 43% year over year, driven by a 46% increase in volume, partially offset by a 5% decrease due to lower realized prices.Gross profit increased 43% to $1 ...